These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36787820)

  • 1. Carboxylated paclitaxel prodrug nanofibers for enhanced chemotherapy.
    Lu S; Hao D; Xiang X; Pei Q; Xie Z
    J Control Release; 2023 Mar; 355():528-537. PubMed ID: 36787820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
    Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Paclitaxel Prodrug Nanoparticles via Redox-Activatable Linkage and Effective Carriers for Enhanced Chemotherapy.
    Lu S; Xia R; Wang J; Pei Q; Xie Z; Jing X
    ACS Appl Mater Interfaces; 2021 Oct; 13(39):46291-46302. PubMed ID: 34558902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymerizable disulfide paclitaxel prodrug for controlled drug delivery.
    Ding Y; Chen W; Hu J; Du M; Yang D
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():386-90. PubMed ID: 25280719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Assembly of pH-Labile Polymer Nanoparticles for Paclitaxel Prodrug Delivery: Formulation, Characterization, and Evaluation.
    Levit SL; Gade NR; Roper TD; Yang H; Tang C
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy.
    Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety.
    Sun Y; Wang S; Li Y; Wang D; Zhang Y; Zhang H; Lei H; Liu X; Sun J; Sun B; He Z
    Acta Biomater; 2023 Feb; 157():417-427. PubMed ID: 36513247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy.
    Ma X; Özliseli E; Zhang Y; Pan G; Wang D; Zhang H
    Biomater Sci; 2019 Jan; 7(2):634-644. PubMed ID: 30534690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
    Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
    Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
    Wang Y; Xin D; Liu K; Zhu M; Xiang J
    Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment.
    Wang D; Huang Y; Yuan J; Wang S; Sheng J; Zhao Y; Zhang H; Wang X; Yu Y; Shi X; He Z; Liu T; Sun B; Sun J
    J Control Release; 2024 Nov; 375():47-59. PubMed ID: 39222794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorinated paclitaxel prodrugs for potentiated stability and chemotherapy.
    Jiang B; Hao D; Li C; Lu S; Pei Q; Xie Z
    J Mater Chem B; 2021 Dec; 9(48):9971-9979. PubMed ID: 34871339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing Precisely Defined Drug-Loaded Nanoparticles by Ring-Opening Polymerization of a Paclitaxel Prodrug.
    Liu J; Pang Y; Bhattacharyya J; Liu W; Weitzhandler I; Li X; Chilkoti A
    Adv Healthc Mater; 2016 Aug; 5(15):1868-73. PubMed ID: 27111757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetal-linked PEGylated paclitaxel prodrugs forming free-paclitaxel-loaded pH-responsive micelles with high drug loading capacity and improved drug delivery.
    Huang D; Zhuang Y; Shen H; Yang F; Wang X; Wu D
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():60-68. PubMed ID: 29025675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocytosis-mediated triple-activable prodrug nanotherapeutics potentiating therapeutic efficacy and security towards solid tumors.
    Fu S; Ma S; Peng X; Qiao H; Zang W; Ye J; Zang W; Li M; Shi K; Ye X; Sun W; Zhai Y
    Colloids Surf B Biointerfaces; 2022 Oct; 218():112723. PubMed ID: 35932558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine.
    Luo C; Sun J; Sun B; Liu D; Miao L; Goodwin TJ; Huang L; He Z
    Small; 2016 Dec; 12(46):6353-6362. PubMed ID: 27689847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.